Taxanes  which are widely used in treatment of numerous cancer types  are well-known to induce hypersensitivity reactions (HSR)  especially in the case of paclitaxel Although the cause of the HSR is commonly thought to be a non-immunological direct effect of the diluent which is used to dissolve paclitaxel  some reports suggest the possibility of the presence of an immunological reaction to the common taxane structure